Per
Bakke
Professor
Visit Address:
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
Phone:
+47 55 97 32 25
+47 992 04 032
E-mail:
Books
- 2004. Lungesykdommer. En basal innføring. 253 pages. ISBN: 82-7674-684-5.
Journal articles
- 2014. Lessons from ECLIPSE: A review of COPD biomarkers. Thorax. 69: 666-672. doi: 10.1136/thoraxjnl-2013-204778
- 2014. Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respiratory Medicine. 108: 86-94. doi: 10.1016/j.rmed.2013.09.004
- 2014. No impact of early real-time PCR screening for respiratory viruses on length of stay and use of antibiotics in elderly patients hospitalized with symptoms of a respiratory tract infection in a single center in Norway. European Journal of Clinical Microbiology and Infectious Diseases. 33: 359-364. doi: 10.1007/s10096-013-1963-0
- 2014. On the simultaneous association analysis of large genomic regions: a massive multi-locus association test. Bioinformatics. 30: 157-164. doi: 10.1093/bioinformatics/btt654
- 2014. Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease. Respirology (Carlton South. Print). 19: 730-734. doi: 10.1111/resp.12292
- 2014. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. American Journal of Respiratory and Critical Care Medicine. 189: 1022-1030. doi: 10.1164/rccm.201311-2006PP
- 2014. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 69: 718-723. doi: 10.1136/thoraxjnl-2012-203151
- 2013. Non-response in telephone surveys of COPD patients does not introduce bias. Journal of Telemedicine and Telecare. 19: 40-44. doi: 10.1177/1357633X12474960
- 2013. Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clinical Respiratory Journal. 7: 245-252. doi: 10.1111/j.1752-699X.2012.00312.x
- 2013. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. European Respiratory Journal. 42: 636-646. doi: 10.1183/09031936.00195212
- 2013. Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. BMC Pulmonary Medicine. 13:64. 10 pages. doi: 10.1186/1471-2466-13-64
- 2013. Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. Respiratory Medicine. 107: 1201-1209. doi: 10.1016/j.rmed.2013.04.016
- 2013. A comparison of nasopharyngeal and oropharyngeal swabbing for the detection of influenza virus by real-time PCR. European Journal of Clinical Microbiology and Infectious Diseases. 32: 381-385. doi: 10.1007/s10096-012-1753-0
- 2013. Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. Sleep Medicine. 14: 1328-1333. doi: 10.1016/j.sleep.2013.08.785
- 2013. Comparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalization. American Journal of Respiratory and Critical Care Medicine. 188: 51-59. doi: 10.1164/rccm.201212-2276OC
- 2013. Mortality by level of emphysema and airway wall thickness. American Journal of Respiratory and Critical Care Medicine. 187: 602-608. doi: 10.1164/rccm.201209-1722OC
- 2013. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respiratory Medicine. 107: 1376-1384. doi: 10.1016/j.rmed.2013.05.001
- 2013. Six-minute-walk test in chronic obstructive pulmonary disease minimal clinically important difference for death or hospitalization. American Journal of Respiratory and Critical Care Medicine. 187: 382-386. doi: 10.1164/rccm.201209-1596OC
- 2013. Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes? Annals of Nutrition and Metabolism. 63: 239-247. doi: 10.1159/000353211
- 2013. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Human Genetics. 132: 431-441. doi: 10.1007/s00439-012-1262-3
- 2013. Increased prevalence of chronic obstructive pulmonary disease in a general population. Respiratory Medicine. 107: 1037-1045. doi: 10.1016/j.rmed.2013.04.008
- 2013. Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. Genomics. 101: 263-272. doi: 10.1016/j.ygeno.2013.02.010
- 2012. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE. 7. 10 pages. doi: 10.1371/journal.pone.0037483
- 2012. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax. 67: 701-708. doi: 10.1136/thoraxjnl-2011-201458
- 2012. Genetic association between human chitinases and lung function in COPD. Human Genetics. 131: 1105-1114. doi: 10.1007/s00439-011-1127-1
- 2012. Recommendations for epidemiological studies on COPD. European Respiratory Journal. 39: 1278-1279. doi: 10.1183/09031936.00011712
- 2012. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 185: 1065-1072. doi: 10.1164/rccm.201110-1792OC
- 2012. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Human Molecular Genetics. 21: 947-957. doi: 10.1093/hmg/ddr524
- 2012. TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. Respiratory research (Online). 13. 10 pages. doi: 10.1186/1465-9921-13-48
- 2012. The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respiratory Medicine. 106: 361-366. doi: 10.1016/j.rmed.2011.10.004
- 2012. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. The International Journal of Chronic Obstructive Pulmonary Disease. 7: 571-576. doi: 10.2147/COPD.S34466
- 2012. Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults. Respirology (Carlton South. Print). 17: 499-505. doi: 10.1111/j.1440-1843.2012.02129.x
- 2012. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 186: 1238-1247. doi: 10.1164/rccm.201206-1013OC
- 2012. Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open. 2. 11 pages. doi: 10.1136/bmjopen-2011-000370
- 2012. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS ONE. 7. 8 pages. doi: 10.1371/journal.pone.0038934
- 2012. Hu antibodies are present in smokers with chronic obstructive pulmonary disease without cancer or neurological disease. Journal of Neuroimmunology. 253: 21-22.
- 2012. Explained variance for blood gases in a population with COPD. Clinical Respiratory Journal. 6: 72-80. doi: 10.1111/j.1752-699X.2011.00248.x
- 2012. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD. 9: 227-234. doi: 10.3109/15412555.2011.650240
- 2012. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. American Journal of Respiratory and Critical Care Medicine. 186: 622-632. doi: 10.1164/rccm.201202-0366OC
- 2011. Recommendations for epidemiological studies on COPD. European Respiratory Journal. 38: 1261-1277. doi: 10.1183/09031936.00193809
- 2011. Candidate genes for chronic obstructive pulmonary disease in two large data sets. European Respiratory Journal. 37: 255-263. doi: 10.1183/09031936.00091709
- 2011. Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax. 66: 1085-1090. doi: 10.1136/thoraxjnl-2011-200017
- 2011. The Association of Genome-Wide Significant Spirometric Loci with Chronic Obstructive Pulmonary Disease Susceptibility. American Journal of Respiratory Cell and Molecular Biology. 45: 1147-1153. doi: 10.1165/rcmb.2011-0055OC
- 2011. Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax. 66: 903-909. doi: 10.1136/thx.2010.146118
- 2011. High prevalence of respiratory symptoms during air travel in patients with COPD. Respiratory Medicine. 105: 50-56. doi: 10.1016/j.rmed.2010.10.006
- 2011. Polymorphisms in surfactant protein D are associated with COPD. American Journal of Respiratory Cell and Molecular Biology. 44: 316-322. doi: 10.1165/rcmb.2009-0360OC
- 2011. Quantitative CT measures of emphysema and airway wall thickness are related to DLCO. Respiratory Medicine. 105: 343-351. doi: 10.1016/j.rmed.2010.10.018
- 2011. Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs. European Journal of Clinical Microbiology and Infectious Diseases. 30: 159-165. doi: 10.1007/s10096-010-1064-2
- 2011. Genome-wide Association Study Identifies BICD1 as a Susceptibility Gene for Emphysema. American Journal of Respiratory and Critical Care Medicine. 183: 43-49. doi: 10.1164/rccm.201004-0541OC
- 2011. On the follow-up of genome-wide association studies: An overall tst for the most promising SNPs. Genetic Epidemiology. 35: 303-309. doi: 10.1002/gepi.20578
- 2011. Excessive costs of COPD in ever-smokers. A longitudinal community study. Respiratory Medicine. 105: 485-493. doi: 10.1016/j.rmed.2010.08.009
- 2011. Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial. BMC Public Health. 11: 893-902. doi: 10.1186/1471-2458-11-893
- 2011. Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease. PLoS ONE. 6. 10 pages. doi: 10.1371/journal.pone.0024395
- 2011. Genome-wide association study of smoking behaviours in patients with COPD. Thorax. 66: 894-902. doi: 10.1136/thoraxjnl-2011-200154
- 2011. Gender differences in COPD: are women more susceptible to smoking effects than men? Response. Thorax. 66: 922-922. doi: 10.1136/thx.2010.153478
- 2011. Changes in forced expiratory volume in 1 second over time in COPD. New England Journal of Medicine. 365: 1184-1192. doi: 10.1056/NEJMoa1105482
- 2011. Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 45: 304-310. doi: 10.1165/rcmb.2010-0294OC
- 2010. Non-response in epidemiological studies - How to cope with it? Respiratory Medicine. 104: 323-324. doi: 10.1016/j.rmed.2009.11.018
- 2010. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nature Genetics. 42: 200-202. doi: 10.1038/ng.535
- 2010. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 104: 283-290. doi: 10.1016/j.rmed.2009.09.015
- 2010. Body composition and plasma levels of inflammatory biomarkers in COPD. European Respiratory Journal. 36: 1027-1033. doi: 10.1183/09031936.00194209
- 2010. Neutrophil Gelatinase-Associated Lipocalin A Biomarker in COPD. Chest. 138: 888-895. doi: 10.1378/chest.09-2718
- 2010. Systemic inflammatory markers in chronic obstructive pulmonary disease – results from the Bergen COPD Cohort Study. European Respiratory Journal. 35: 540-548. doi: 10.1183/09031936.00088209
- 2010. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. American Journal of Respiratory and Critical Care Medicine. 181: 353-359. doi: 10.1164/rccm.200907-1008OC
- 2010. Transthoracic fine-needle aspiration in the aetiological diagnosis of communityacquired pneumonia. Clinical Microbiology and Infection. 16: 909-911. doi: 10.1111/j.1469-0691.2009.03000.x
- 2010. Multistudy Fine Mapping of Chromosome 2q Identifies XRCC5 as a Chronic Obstructive Pulmonary Disease Susceptibility Gene. American Journal of Respiratory and Critical Care Medicine. 182: 605-613. doi: 10.1164/rccm.200910-1586OC
- 2010. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respiratory Medicine. 104: 986-994. doi: 10.1016/j.rmed.2010.02.020
- 2010. Socioeconomic risk factors for lung function decline in a general population. European Respiratory Journal. 36: 480-487. doi: 10.1183/09031936.00186509
- 2010. Testing for Weak Signal. Genetic Epidemiology. 34: 938-939.
- 2010. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics. 42: 436-U75. doi: 10.1038/ng.572
- 2010. Healthy hire effect, job selection and inhalation exposure among young adults with asthma. European Respiratory Journal. 36: 517-523. doi: 10.1183/09031936.00125709
- 2010. HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer. Clinical Respiratory Journal. 4: 168-175. doi: 10.1111/j.1752-699X.2009.00171.x
- 2010. alpha(1)-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts. Chest. 138: 1125-1132. doi: 10.1378/chest.10-0746
- 2010. Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD. COPD. 7: 262-268. doi: 10.3109/15412555.2010.496821
- 2010. Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clinical Respiratory Journal. 4: 89-96. doi: 10.1111/j.1752-699X.2009.00154.x
- 2010. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 65: 480-485. doi: 10.1136/thx.2009.122002
- 2010. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. European Journal of Neurology. 17: 1352-1357. doi: 10.1111/j.1468-1331.2010.03036.x
- 2010. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health and Quality of Life Outcomes. 8. doi: 10.1186/1477-7525-8-107
- 2009. Non-response in epidemiological studies - How to cope with it? Respiratory Medicine. Published 2009-12-24. doi: 10.1016/j.rmed.2009.11.018
- 2009. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 104: 283-290. doi: 10.1016/j.rmed.2009.09.015
- 2009. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. European Respiratory Journal. 34: 858-865. doi: 10.1183/09031936.00167908
- 2009. Quantitative CT Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms. American Journal of Respiratory and Critical Care Medicine. Published 2009-11-19.
- 2009. Aspects of healthcare utilisation in self-reported obstructive lung disease. Clinical Respiratory Journal. 3: 34-41. doi: 10.1111/j.1752-699X.2008.00106.x
- 2009. How expensive is comorbidity in COPD? Respiratory Medicine. 103: S7-S7. doi: 10.1016/S0954-6111(09)70018-6
- 2009. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genetics. 5. 8 pages. doi: 10.1371/journal.pgen.1000421
- 2009. Relationships between hand-rolled cigarettes and primary lung cancer: A Norwegian experience. Clinical Respiratory Journal. 3: 152-160. doi: 10.1111/j.1752-699X.2008.00125.x
- 2009. Occupational exposure and incidence of respiratory disorders in a general population. Scandinavian Journal of Work, Environment and Health. 35: 454-460.
- 2009. Effect of reducing indoor air pollution on women’s respiratory symptoms and lung function: The RESPIRE Randomized Trial, Guatemala. American Journal of Epidemiology. 170: 211-220. doi: 10.1093/aje/kwp100
- 2009. Genetikk ved kronisk obstruktiv lungesykdom. Tidsskrift for Den norske legeforening. 129: 2104-2107. doi: 10.4045/tidsskr.09.0713
- 2009. Case–control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clinical Respiratory Journal. doi: 10.1111/j.1752-699X.2009.00154.x
- 2009. Prevalens av hjemmerespiratorbehandling i Norge. Tidsskrift for Den norske legeforening. 129: 2094-2097.
- 2009. CTLA4 gene polymorphisms are associated with chronic bronchitis. European Respiratory Journal. 34: 598-604. doi: 10.1183/09031936.00141808
- 2009. Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Human Molecular Genetics. 18: 2053-2062. doi: 10.1093/hmg/ddp111
- 2008. Designing studies for diagnostic tests. Clinical Respiratory Journal. 2: 72-75. doi: 10.1111/j.1752-699X.2008.00087.x
- 2008. No increase in response rate by adding a web response option to a postal population survey: A randomized trial. Journal of Medical Internet Research. 9: e40. doi: 10.2196/jmir.9.5.e40
- 2008. Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. Clinical Respiratory Journal. 2: 10-25. doi: 10.1111/j.1752-699X.2008.00080.x
- 2008. Group cognitive behavioural therapy for anxiety, depression and sleep disturbances in patients with chronic respiratory illness. International Journal of Psychology. 43: 16-16.
- 2008. Clinical data discriminating between adults with positive and negative results on bronchodilator testing. The International Journal of Tuberculosis and Lung Disease. 12: 205-213.
- 2008. Repeatability of health economic data in COPD. Respiratory Medicine. 102: 1556-1562. doi: 10.1016/j.rmed.2008.06.008
- 2008. Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Respiratory Medicine. 102: 1460-1467. doi: 10.1016/j.rmed.2008.04.002
- 2008. Asthma and health-related quality of life - effect of adjusting for potential confounders. Clinical Respiratory Journal. 2: 106-115. doi: 10.1111/j.1752-699X.2008.00047.x
- 2008. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine. 102: 399-406. doi: 10.1016/j.rmed.2007.10.012
- 2007. Changes in Respiratory Symptoms and Health-Related Quality of Life. Chest. 131: 1890-1897. doi: 10.1378/chest.06-2629
- 2007. Cognitive behavioural therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease. Journal of Psychosomatic Research. 63: 323-323.
- 2007. Defining the lower limit of normal for FEV1/FVC - From the authors. American Journal of Respiratory and Critical Care Medicine. 176: 101-102.
- 2007. Feasible and simple exclusion criteria for pulmonary reference populations. Thorax. 62: 792-798.
- 2007. Bronchodilator response to adrenergic (beta) (2)-agonists: Relationship to symptoms in an adult community. Respiratory Medicine. 101: 1183-1190. doi: 10.1016/j.rmed.2006.11.007
- 2007. Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Journal of Thoracic Oncology. 2: S431-S431.
- 2007. Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway. Respiratory Medicine. 101: 1251-1257. doi: 10.1016/j.rmed.2006.10.021
- 2007. Exposure to environmental tobacco smoke in a general population. Respiratory Medicine. 101: 277-285. doi: 10.1016/j.rmed.2006.05.010
- 2007. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. American Journal of Respiratory and Critical Care Medicine. 176: 167-173. doi: 10.1164/rccm.200611-1723OC
- 2006. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. European Respiratory Journal. 27: 682-688. doi: 10.1183/09031936.06.00057005
- 2006. Opplæring av pasienter i riktig bruk av inhalasjonsmedisiner. Tidsskrift for Den norske legeforening. 126: 312-314.
- 2006. Astma og KOLS i en generell voksen befolkning i Vest-Norge. Fagbladet Allergi i praksis. 3. 24-31.
- 2006. Post-bronchodilator spirometry reference values in adults and implications for disease management. American Journal of Respiratory and Critical Care Medicine. 173: 1316-1325. doi: 10.1164/rccm.200601-0230C
- 2006. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta(2)-agonist. Pulmonary Pharmacology & Therapeutics. 19: 272-280.
- 2006. Nordic physician's management of asthma and chronic obstructive pulmonary disease. Respiratory Medicine. 100: S31-S37. doi: 10.1016/j.rmed.2006.03.025
- 2006. Does smoking cessation improve quality of life in patients with coronary heart disease? Scandinavian Cardiovascular Journal. 40: 11-16. doi: 10.1080/14017430500384855
- 2006. Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 13: 274-280. doi: Se sammendragsfelt
- 2006. Obstruktiv lungesykdom hos barn og voksne. Presentasjon av et integrert undervisningsopplegg i allmennmedisin. UNIPED (Tromsø). 29: 24-30.
- 2005. The incidence of adult asthma: a review. The International Journal of Tuberculosis and Lung Disease. 9: 603-612.
- 2005. Hospital doctors' and nurses' knowledge of how to use inhalation devices correctly. The International Journal of Tuberculosis and Lung Disease. 9: 586-587.
- 2005. Assessment of lung volumes in children and adolescents: comparison of two plethysmographic techniques. Clinical Physiology and Functional Imaging. 25: 62-68.
- 2005. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respiratory Medicine. 99: 186-195. doi: 10.1016/j.rmed.2004.06.006
- 2005. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. The International Journal of Tuberculosis and Lung Disease. 8: 926-932.
- 2005. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 60: 842-847. doi: 10.1136/thx.2005.043943
- 2005. Behandling av obstruktiv søvnapné. Tidsskrift for Den norske legeforening. 125: 199.
- 2005. Predictors of smoking cessation in patients admitted for acute coronary heart disease. Journal of Cardiovascular Risk. 12: 472-477.
- 2005. Scandinavian COPD research symposium. Respiratory Medicine. 99.
- 2005. The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. American Journal of Respiratory and Critical Care Medicine. 172: 61-66. doi: 10.1164/rccm.200409-1158OC
- 2005. Indoor exposures and respiratory symptoms in a Norwegian community sample. Thorax. 60: 937-942. doi: 10.1136/thx.2004.025973
- 2005. Et tverrfaglig undervisningsopplegg om obstruktiv lungesykdom i allmennpraksis. Tidsskrift for Den norske legeforening. 125: 465-465.
- 2005. Røykevaner blant medisinstudenter i Bergen. Tidsskrift for Den norske legeforening. 125: 276-277.
- 2004. Trends in symptoms of obstructive lung disease in Norway. The International Journal of Tuberculosis and Lung Disease. 8: 1416-1422.
- 2004. Trends in symptoms of obstructive lung disease in Norway. The International Journal of Tuberculosis and Lung Disease. 8: 1416-1422.
- 2004. Bias in retrospective studies of trends in asthma incidence. European Respiratory Journal. 23: 281-286.
- 2004. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. European Respiratory Journal. 23: 589-594.
- 2004. The effect of educational level on the incidence of asthma and respiratory symptoms. Respiratory Medicine. 98: 730-736.
- 2004. Atopic and non-atopic asthma in a farming and a general population. American Journal of Industrial Medicine. 46: 396-399.
- 2004. Interpreting and reporting results. The International Journal of Tuberculosis and Lung Disease. 8: 1506-1509.
- 2004. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatrica. 93: 1294-1300.
- 2004. Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. Scandinavian Journal of Public Health. 31: 411-417.
- 2004. Chronic airway symptoms and lung function among women in a rural community in Guatemala with high indoor air pollution levels. Epidemiology. 15: S79-S80.
- 2004. Pulmonary gas exchange and educational level: a community study. European Respiratory Journal. 23: 583-588.
- 2003. Factors affecting growth of FEV1. Monaldi Archives for Chest Disease. 59: 103-107.
- 2003. Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. American Journal of Epidemiology. 157: 558-566.
- 2003. Long-term changes in adult asthma prevalence. European Respiratory Journal. 21: 468-472.
- 2003. Does smoking affect the outcome of patient education and self-management in asthmatics? Patient Education and Counseling. 49: 91-97.
- 2003. Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. Scandinavian Journal of Public Health. 31: 1-7.
- 2003. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. European Respiratory Journal. 3s-9s.
- 2002. Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. American Journal of Epidemiology. 155: 572-576.
- 2002. Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. European Respiratory Journal. 19: 599-605.
- 2002. Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. Journal of Clinical Epidemiology. 55: 775-781.
- 2002. Occupational airborne exposure and the incidence of respiratory symptoms and asthma. American Journal of Respiratory and Critical Care Medicine. 166: 933-938.
- 2002. Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. Respiratory Medicine. 96: 424-431.
- 2002. Effekter av astmaopplæring i en randomisert, kontrollert undersøkelse. Tidsskrift for Den norske legeforening. 122: 2702-2706.
- 2001. Lungescreening: Kan gi grønt lys for røykere. Dagens medisin. 11. Published 2001-05-30.
- 2001. Relationship of occupational exposure to respiratory symptoms and asthma in a general population sample self-reported versus interview based exposure data. American Journal of Epidemiology. 154: 477-483.
- 2001. Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial. European Respiratory Journal. 17: 206-213.
- 2001. Standardized submaximal exercise testing in never smokers: A normative study. Clinical Physiology and Functional Imaging. 21: 629-636.
- 2001. Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clinical Physiology and Functional Imaging. 21: 648-660.
- 2001. Relationship between occupational exposure, estimated by two job-exposure matrices, and lung function in French, Dutch, and Norwegian community studies. European Respiratory Review. 11: 91-97.
- 2001. Bronchitic symptoms and their relation to FEV1 in Italy, Sweden and Norway. European Respiratory Review. 11: 74-79.
- 2001. Increased circulating levels of alpha-1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs. European Respiratory Journal. 17: 1105-1111.
- 2000. Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. The International Journal of Tuberculosis and Lung Disease. 4: 649-656.
- 2000. Et forsvarlig blikk på bupropion. Lungeforum. 10: 113-115.
- 2000. Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. The International Journal of Tuberculosis and Lung Disease. 4: 649-656.
- 2000. Et forsvarlig blikk på bupropion. Lungeforum. 10: 113-115.
- 2000. Study design. European Respiratory Monograph. 15: 128-153.
- 2000. Comparison of respiratory symptoms questionaires. The International Journal of Tuberculosis and Lung Disease. 4: 83-90.
- 2000. Comparison of respiratory symptoms questionnaires. The International Journal of Tuberculosis and Lung Disease. 4: 83-90.
- 2000. Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. Respiratory Medicine. 94: 1057-1064.
- 2000. Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. Respiratory Medicine. 94: 279-287.
- 2000. Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. Respiratory Medicine. 94: 279-287.
- 2000. Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. Respiratory Medicine. 94: 279-287.
- 2000. Smoking status, disease duration, and educational level in females, are related to asthma school participation. European Respiratory Journal. 15: 1022-1025.
- 2000. Smoking status, disease duration, and educational level in females, are related to asthma school participation. European Respiratory Journal. 15: 1022-1025.
- 2000. Prevention of death from asthma. International Review of Asthma. 2: 50-58.
- 2000. Prevention of death from asthma. International Review of Asthma. 2: 50-58.
- 2000. Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. European Respiratory Review. 10: 457-462.
- 2000. Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. European Respiratory Review. 10: 457-462.
- 2000. Obstructive lung disease in patients within the hospital in the Nordic countries. European Respiratory Review. 10: 428-431.
- 2000. Obstructive lung disease in patients within the hospital in the Nordic countries. European Respiratory Review. 10: 428-431.
- 2000. Performance of population-specific job exposure-matrices (JEM). Occupational and Environmental Medicine. 57: 126-132.
- 2000. Performance of population-specific Job exposure-matrices (JEM). Occup Environ Med. 57: 126-132.
- 2000. Snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 120: 1616-1621.
- 2000. Snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 120: 1616-1621.
- 2000. I hvor stor grad snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 120: 1616-1621.
- 2000. Nonpharmacological intervention in obstructive lung disease. European Respiratory Review. 10: 391-392.
- 2000. Nonpharmacological intervention in obstructive lung disease. European Respiratory Review. 10: 391-392.
- 1999. Reproducibility of indoor environment characteristics obtained in a walk through questionaire. A pilot study. Indoor Air. 9: 26-32.
- 1999. Comparison between two respiratory symptomquestionnaires, by sex and smoking habits. American Journal of Respiratory and Critical Care Medicine. 159: S:A134.
- 1999. Decreasing response to respiratory disease surveys. Norwegian Respiratory Journal. 9: 12.
- 1999. The association of sex, age and smoking to respiratory symptoms in a longitudinal study in western Norway. European Respiratory Journal. 14: 19.
- 1999. Incidence and remission rates of respiratory symptoms by sex, age and smoking in a Norwegian community during twelve years. American Journal of Respiratory and Critical Care Medicine. 159: S:A134.
- 1999. New epidemiological interpretations of the average attributable fraction from a game theoretical perspective. American Journal of Respiratory and Critical Care Medicine. 159: S:A320.
- 1999. The risks of snoring and day-time hypersomnolence in a general Norwegian population. American Journal of Respiratory and Critical Care Medicine. 159: S:A562.
- 1999. Asthma and wheezing are increasing in repeated community surveys of adults. European Respiratory Journal. 14: 216.
Book sections
- 2000. Study design. 128-153. In:
- 2000. Respiratory Epidemiology in Europe.
More information in national current research information system (CRIStin)
